What are the differential diagnoses and recommended work‑up for a woman in her late 80s with chronic kidney disease and a newly elevated parathyroid hormone level?

Differential Diagnosis and Work-Up for Elevated PTH in an Elderly Woman with CKD

In a woman in her late 80s with CKD and newly elevated PTH, the primary differential is secondary hyperparathyroidism (SHPT) due to CKD-mineral bone disorder, but you must actively exclude primary hyperparathyroidism (PHPT) by checking serum calcium and phosphate levels—hypercalcemia with elevated PTH indicates PHPT, while hypocalcemia or normocalcemia with hyperphosphatemia suggests SHPT.

Differential Diagnoses

The elevated PTH in this clinical context has three main possibilities:

1. Secondary Hyperparathyroidism (SHPT) - Most common in CKD, driven by hyperphosphatemia, hypocalcemia, vitamin D deficiency, and high phosphate intake 1

2. Primary Hyperparathyroidism (PHPT) - Can coexist with CKD and is characterized by hypercalcemia with elevated PTH 2, 3

3. Tertiary Hyperparathyroidism - Autonomous PTH secretion after prolonged SHPT (less likely without dialysis history)

Critical Initial Work-Up

Immediate Laboratory Assessment

Order these labs to distinguish SHPT from PHPT:

• Serum calcium (corrected for albumin) - The key discriminator

  • Hypercalcemia → strongly suggests PHPT 2, 3
  • Hypocalcemia or normocalcemia → consistent with SHPT 1

• Serum phosphate

  • Hyperphosphatemia → typical of SHPT in CKD 1
  • Hypophosphatemia → suggests PHPT 4

• 25-hydroxyvitamin D level

  • Deficiency is a modifiable driver of SHPT 1
  • Target ≥30 ng/mL for optimal bone health 5

• Alkaline phosphatase - Marker of bone turnover

Assess PTH Trend

A single elevated PTH is insufficient for diagnosis. The 2017 KDIGO guidelines emphasize that you should evaluate patients with PTH levels "progressively rising or persistently above the upper normal limit" rather than reacting to a single value 1. Review prior PTH values if available—modest increases may represent appropriate adaptive responses to declining kidney function 1.

Algorithmic Approach Based on Calcium Levels

If Hypercalcemia is Present:

1. Suspect PHPT - This is the critical finding that changes management 2, 3

2. Order parathyroid imaging:

   • Sestamibi scan (technetium-99m sestamibi scintigraphy)
   • Ultrasound of parathyroid glands
   • These identify parathyroid adenomas 2, 3

3. Consider surgical referral if adenoma confirmed, though age and comorbidities must be weighed 2

4. Medical management alternative: Cinacalcet can be used if surgery is too high-risk in this elderly patient 2

If Normocalcemia or Hypocalcemia:

1. Diagnose SHPT - Proceed with evaluation of modifiable factors 1

2. Assess and correct modifiable drivers:

   • Hyperphosphatemia - Restrict dietary phosphate intake, focusing on phosphate source (avoid processed foods with phosphate additives, limit animal protein) 1
   • Hypocalcemia - May require calcium supplementation, but avoid excessive calcium-based phosphate binders 1
   • Vitamin D deficiency - Supplement nutritional vitamin D (cholecalciferol or ergocalciferol) to achieve 25-(OH)D ≥30 ng/mL 5
   • High phosphate intake - Dietary counseling even if serum phosphate is normal, as excess intake promotes SHPT 1

3. Monitor PTH trend - Recheck in 3-6 months to assess response to interventions

Treatment Considerations for SHPT in This Population

For severe and progressive SHPT despite correcting modifiable factors:

• Reserve calcitriol or vitamin D analogues for CKD stage 4-5 with severe, progressive hyperparathyroidism 1
• Avoid routine use of activated vitamin D in earlier CKD stages due to hypercalcemia risk without proven cardiovascular or mortality benefit (PRIMO and OPERA trials showed increased hypercalcemia without cardiac benefit) 1
• Low-dose active vitamin D may help control PTH when combined with nutritional vitamin D and dietary phosphate restriction 5

Critical Pitfalls to Avoid

1. Don't assume all elevated PTH in CKD is secondary - Always check calcium to exclude PHPT, which requires different management 2, 3, 6

2. Don't treat a single elevated PTH value - Look for progressive rise or persistent elevation 1

3. Don't overlook vitamin D deficiency - This is easily correctable and may significantly improve PTH 1

4. Don't use activated vitamin D routinely - Risk of hypercalcemia outweighs benefits in most CKD patients not on dialysis 1

5. Don't ignore phosphate intake - High dietary phosphate drives SHPT even when serum phosphate appears normal in early CKD 1

Age-Specific Considerations

In a patient in her late 80s, surgical intervention for PHPT carries higher risk 2. If PHPT is confirmed, medical management with cinacalcet is a reasonable alternative, though you may need to switch between cinacalcet and calcitriol based on calcium levels 2. The goal is preventing complications (fractures, bone pain, cardiovascular events) while minimizing treatment-related adverse effects like hypercalcemia or hypocalcemia.